Cold Spring Harbor Laboratory
Records under this name other than the patents Cold Spring Harbor Laboratory holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 56 patents it holds.
Back to Cold Spring Harbor Laboratory
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,399,248 | Methods of Using MIR34 as a Biomarker for TP53 Functional Status Formerly held In force · High confidence | In force | High confidence | |
| US 9,717,750 | Compositions and Methods for Modulation of SMN2 Splicing in a Subject Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,584,349 | Nucleotide Sequences Encoding Fasciated EAR3 (FEA3) and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,643,665 | Nucleotide Sequences Encoding Fasciated EAR3 (FEA3) and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,701,979 | Nucleotide Sequences Encoding Fasciated EAR3 (FEA3) and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,581,841 | Display Device Formerly held In force · High confidence | In force | High confidence | |
| US 11,406,647 | Method and compositions for forming a copper-containing complex and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,178,825 | Method and compositions for forming a copper-containing complex and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,137,907 | Orthotopic and Genetically Tractable Non-Human Animal Model for Liver Cancer and the Uses Thereof Term ended Term ended Nov 4, 2026 · High confidence | Term ended | Term ended Nov 4, 2026 | High confidence |
| US 8,946,183 | Compositions and Methods for Modulation of SMN2 Splicing Term ended Term ended Aug 7, 2026 · High confidence | Term ended | Term ended Aug 7, 2026 | High confidence |